GL1X · GenesisL1 explorer

MolNFT v1 · #100489 · protein

Discovery of an irreversible HCV NS5B polymerase inhibitor

4MZ4 · RNA-directed RNA polymerase: “Discovery of an irreversible HCV NS5B polymerase inhibitor”. X-ray diffraction, 2 ligands (2F3, PO4), 18 pockets (best druggability 0.80). MolNFT v1 #100489 on GenesisL1: 3D structure, binding sites and…

PDB
4MZ4
Type
protein
Length
1,123 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
O92972
Ligands
2F3, PO4
Pockets
18 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein56349% helix, 15% strandO92972
BRNA-directed RNA polymerase (EC 2.7.7.48)protein56048% helix, 15% strandO92972

Ligands and binding sites

  • 2F3 · 1-[(2-chloroquinolin-3-yl)methyl]-6-fluoro-5-methyl-3-(2-oxo-1,2-dihydropyridin-3-yl)-1H-indole-2-carboxylic acid · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

18 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110840.800.82782F3
211120.800.81862F3
31090.500.8119empty
41190.460.7821empty
51210.450.7718empty

Interfaces

1 interface between chains.

  • A–B · 995 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 4MZ4 · Discovery of an Irreversible HCV NS5B Polymerase Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.